Soft Tissue Sarcoma: Related News

On Our Blog

Pictured: Marc Ladanyi
Gene Mutation Linked to Aggressive Form of Sarcoma Affecting Children and Young Adults

A newly discovered gene mutation appears to be the driving force behind a particularly aggressive form of embryonal rhabdomyosarcoma, a rare cancer of the skeletal muscle.

August 6, 2014
Five Questions for Sarcoma and Melanoma Expert Mark Dickson

In this Q&A and video, medical oncologist Mark Dickson discusses his approach to treating sarcoma and melanoma and how he develops individual treatment plans for each patient.

July 21, 2014
Pictured: William Tap
Meet Medical Oncologist William Tap

In this Q&A, medical oncologist William Tap describes Memorial Sloan Kettering’s expertise in providing cutting-edge treatment for people with different types of soft tissue sarcoma.

July 14, 2014
Pictured: Sandra D’Angelo
Meet Medical Oncologist Sandra D’Angelo

Medical oncologist Sandra D’Angelo, who specializes in caring for patients with rare cancers such as melanoma, soft tissue sarcoma, and Merkel cell carcinoma, talks about the team approach and the importance of empowering patients.

March 21, 2014
Pictured: George Plitas
When the Distinctions of Cancer Blur

The correct identification and naming of a tumor’s type is increasingly important in the era of personalized medicine, and tumors that exhibit features of more than one type can complicate that process.

March 14, 2014
Pictured: William Tap
New Information about Diagnosing and Treating Soft Tissue Sarcoma at Memorial Sloan Kettering

We offer unparalleled expertise in understanding and treating the more than 70 subtypes of soft tissue sarcoma identified to date.

January 29, 2014
Pictured: Mrinal Gounder
Meet Medical Oncologist Mrinal Gounder

Medical oncologist Mrinal Gounder describes our sophisticated and multidisciplinary approach to care for patients with sarcomas of the soft tissue and bone.

January 13, 2014
Pictured: Guido Dalbagni
Meet Urologic Cancer Surgeon Guido Dalbagni

Dr. Dalbagni – who cares for patients with bladder cancer, kidney cancer, penile cancer, and sarcomas – explains treatments offered at Memorial Sloan Kettering, which can help patients maintain their quality of life.

April 23, 2013
Pictured: Gary Schwartz & Mark Dickson
Studies Show Promise for Treatment Advances in Several Types of Sarcoma

Two clinical trials of targeted therapies led by Memorial Sloan Kettering investigators show promising results against different types of sarcoma.

April 22, 2013
Pictured: Ron Kraemer
Ron’s Story about Soft Tissue Sarcoma

To treat his soft tissue sarcoma, 50-year-old Ron Kraemer chose Memorial Sloan Kettering for care and support that could keep him playing music and working as a personal fitness trainer.

March 22, 2013
Pictured: Ping Chi
At Work: Physician-Scientist Ping Chi

Dr. Chi, a physician-scientist and member of the Human Oncology and Pathogenesis Program, studies genetic and epigenetic changes that cause cancer.

November 2, 2012
Cancer Genomics: Improved Understanding of Molecular Changes in Tumors Produces More-Specialized Treatments

With the genomics revolution, scientists and physicians have increasingly been able to peer at the inner workings of tumor cells and pinpoint the specific genetic changes that transform them from their cells of origin into cancer.

September 21, 2012
Pictured: Mary McCabe
Cancer Survivorship: An Interview with Mary McCabe

In 2003, Mary McCabe was recruited to lead Memorial Sloan Kettering Cancer Center’s Cancer Survivorship Initiative and since that time has worked to develop a comprehensive program for cancer survivors, which includes follow-up care, research, and education and training.

July 1, 2011
Treating Rare Cancers

Memorial Sloan Kettering physicians have experience and specialized expertise in caring for people with uncommon cancers.

April 1, 2011